This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas. The ...
The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...
If you have used Depo-Provera, you may have heard recent reports suggesting a potential link between this birth control injection and an increased risk of brain tumors known as meningiomas. It is ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DEPO-PROVERA contains the active ingredient medroxyprogesterone ...
MARLTON, N.J., March 12, 2025 /PRNewswire/ -- A growing number of women who received Depo-Provera injections are coming forward with serious health concerns following new research linking the ...
The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called ...
THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...
Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback